Mereo BioPharma Group Balance Sheet Health
Financial Health criteria checks 6/6
Mereo BioPharma Group has a total shareholder equity of $50.5M and total debt of $4.4M, which brings its debt-to-equity ratio to 8.7%. Its total assets and total liabilities are $66.5M and $16.0M respectively.
Key information
8.7%
Debt to equity ratio
US$4.39m
Debt
| Interest coverage ratio | n/a |
| Cash | US$57.42m |
| Equity | US$50.54m |
| Total liabilities | US$15.96m |
| Total assets | US$66.50m |
Recent financial health updates
Is Mereo BioPharma Group (NASDAQ:MREO) Weighed On By Its Debt Load?
Apr 07
Is Mereo BioPharma Group (NASDAQ:MREO) Using Debt Sensibly?
Nov 25Recent updates
Is Mereo BioPharma Group (NASDAQ:MREO) Weighed On By Its Debt Load?
Apr 07Is Mereo BioPharma Group (NASDAQ:MREO) Using Debt Sensibly?
Nov 25Mereo stock rises 12% on FDA fast-track status for lung disease drug alvelestat
Oct 17Rubric Capital boosts Mereo BioPharma board nominees slate to five
Oct 03Mereo BioPharma: An Activist Pressure With A Potentially Significant Upside
Sep 22Mereo activist investor Rubric asks board again to hold general meeting, nominate directors
Sep 14Mereo BioPharma Group regains compliance with Nasdaq's listing rule
Jul 05Mereo BioPharma: Activist Pressure In A Net-Net Biopharma
Jun 17Mereo BioPharma: Anti-TIGIT Developer In Mid-Stage Development
Dec 08Mereo BioPharma and Cancer Focus Fund ink partnership for ovarian cancer study
Apr 30Financial Position Analysis
Short Term Liabilities: MREO's short term assets ($63.8M) exceed its short term liabilities ($9.5M).
Long Term Liabilities: MREO's short term assets ($63.8M) exceed its long term liabilities ($6.5M).
Debt to Equity History and Analysis
Debt Level: MREO has more cash than its total debt.
Reducing Debt: MREO's debt to equity ratio has reduced from 65.6% to 8.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MREO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MREO has sufficient cash runway for 2.4 years if free cash flow continues to grow at historical rates of 8% each year.